Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Cited by (1,019)

Items 301–400 of 1,019

1. Echocardiography in Heart Failure
   James N. Kirkpatrick, Mani A. Vannan, Jagat Narula, Roberto Miguel Lang · 2007 · Journal of the American College of Cardiology
2. JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
   Akihiko Nogami, Takashi Kurita, Haruhiko Abe, Kenji Andò, Toshiyuki Ishikawa, Katsuhiko Imai, Akihiko Usui, Kaoru Okishige, Kengo Kusano, Koichiro Kumagai et al. · 2021 · Circulation Journal
3. Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?
   Chow, Theodore, Kereiakes, Dean J., Onufer, John, Woelfel, Alan, Gursoy, Sinan, Peterson, Brett J., Brown, Mark L., Pu, Wenji, Benditt, David G. · 2008 · Journal of the American College of Cardiology
4. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial
   Eric J. Velazquez, Kerry L. Lee, Christopher M. O’Connor, Jae K. Oh, Robert O. Bonow, Gerald M. Pohost, Arthur Michael Feldman, Daniel B. Mark, Julio A. Panza, George S. Sopko et al. · 2007 · Journal of Thoracic and Cardiovascular Surgery
5. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
   Takeshi Kitai, Shun Kohsaka, Takao Kato, Eri Toda Kato, Kimi Sato, KANAKO TERAMOTO, Hidenori Yaku, Eiichi Akiyama, Masahiko Ando, Chisato Izumi et al. · 2025 · Circulation Journal
6. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
   Jonathan Paul Piccini, Jeffrey S. Berger, C. M. O'Connor · 2009 · European Heart Journal
7. MRI-Guided Ventricular Tachycardia Ablation
   Timm Michael Dickfeld, Jing Tian, Ghada Ahmad, Alejandro Jiménez, Aharon Turgeman, Richard S. Kuk, Matthew C. Peters, ANASTASIOS P. SALIARIS, MAGDI M. SABA, Stephen Ross Shorofsky et al. · 2011 · Circulation Arrhythmia and Electrophysiology
8. Temporal Trends and Patterns in Mortality After Incident Heart Failure
   Nathalie Conrad, Andrew Judge, Dexter Canoy, Jenny Tran, Ana‐Catarina Pinho‐Gomes, Elizabeth R. C. Millett, Gholamreza Salimi‐Khorshidi, John G.F. Cleland, John J.V. McMurray, Kazem Rahimi · 2019 · JAMA Cardiology
9. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
   Christian Sticherling, Francisco R. Marín, David H. Birnie, Giuseppe Boriani, Hugh G Calkins, Gheorghe‐Andrei Dan, Michele Massimo Gulizia, Sigrun Halvorsen, Gerhard Hindricks, Karl‐Heinz Kück et al. · 2015 · EP Europace
10. Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
    Ratika Parkash, George A. Wells, Jean Lucien Rouleau, Mario R. Talajic, Vidal Essebag, Allan Skanes, Stephen B. Wilton, Atul Verma, Jeff S. Healey, Laurence Sterns et al. · 2022 · Circulation
11. Heart Failure in Women
    Eileen Hsich, Ileana L. Piña · 2009 · Journal of the American College of Cardiology
12. Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy
    Pamela N. Peterson, Stacie L. Daugherty, Yongfei Wang, Humberto J. Vidaillet Jr., Paul A. Heidenreich, Jeptha P. Curtis, Frederick A. Masoudi · 2009 · Circulation
13. 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy
    Michele Brignole, Angelo Auricchio, Gonzalo Barón‐Esquivias, Pierre Bordachar, Giuseppe Boriani, Ole A. Breithardt, John G.F. Cleland, Jean-Claude Deharo, Victoria Delgado, Perry M Elliott et al. · 2014 · Revista Española de Cardiología (English Edition)
14. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary
    Jeffrey A. Towbin, William John McKenna, Dominic James Abrams, Michael John Ackerman, Hugh G Calkins, Francisco Darrieux, James P. Daubert, Christian de Chillou, Eugene Christopher DePasquale, Milind Y. Desai et al. · 2019 · Heart Rhythm
15. Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy
    Gold, Michael R., Ip, John H., Costantini, Otto, Poole, Jeanne E., McNulty, Steven, Mark, Daniel B., Lee, Kerry L., Bardy, Gust H. · 2008 · Circulation
16. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk)
    Axel Bauer, Petra Barthel, Raphael Schneider, Kurt Ulm, Alexander Müller, Anke Joeinig, Raphael Stich, Antti M. Kiviniemi, Katerina Hnatkova, Heikki V. Huikuri et al. · 2008 · European Heart Journal
17. Contemporary Use of Digoxin in the Management of Cardiovascular Disorders
    Mihai Gheorghiade, Dirk Jan van Veldhuisen, Wilson S. Colucci · 2006 · Circulation
18. The Relation Between Patients’ Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries
    Sana M. Al‐Khatib, F. Lee Lucas, James G. Jollis, David J. Malenka, David E. Wennberg · 2005 · Journal of the American College of Cardiology
19. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)
    David H. Birnie, Jeff S. Healey, George A. Wells, Felix Ayala Paredes, Benoit Coutu, Glen Sumner, Giuliano Becker, Atul Verma, François Philippon, Eli Kalfon et al. · 2018 · European Heart Journal
20. Prediction of Mortality in Clinical Practice for Medicare Patients Undergoing Defibrillator Implantation for Primary Prevention of Sudden Cardiac Death
    Kenneth C. Bilchick, George J. Stukenborg, Sandeep Kamath, Alan Cheng · 2012 · Journal of the American College of Cardiology
21. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices
    Philip B. Adamson · 2009 · Current Heart Failure Reports
22. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure
    Marie Bayer Elming, Jens Cosedis Nielsen, Jens Haarbo, Lars Melgaard Videbæk, Eva Korup, James Signorovitch, Line Lisbeth Olesen, Per Rossen Hildebrandt, Flemming Hald Steffensen, Niels Eske Bruun et al. · 2017 · Circulation
23. Cardiac Sympathetic Imaging With mIBG in Heart Failure
    Ignasi Carrió, Martín Cowie, Junichi Yamazaki, James E. Udelson, Paolo Guido Camici · 2010 · JACC. Cardiovascular imaging
24. Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy
    Andrea Di Marco, Pamela Frances Brown, Joshua Bradley, Gaetano Nucifora, Eduard Claver, Fernando de Frutos, Paolo Dallaglio, Josep Comin Colet, Ignasi Anguera, Chris Miller et al. · 2021 · Journal of the American College of Cardiology
25. Heart Failure Care in the Outpatient Cardiology Practice Setting
    Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, James Thomas Heywood, Mark L. McBride, Mandeep R. Mehra, Christopher M. O’Connor et al. · 2008 · Circulation Heart Failure
26. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study
    Cecilia Marianne Linde, Michael Robert Gold, William T. Abraham, Martin St. John Sutton, Stefano Ghio, Jeff Cerkvenik, Jean‐Claude Daubert, on behalf of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group · 2013 · European Heart Journal
27. Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator
    Jeptha P. Curtis · 2009 · JAMA
28. Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices
    Arthur Reshad Garan, melana yuzefpolskaya, P.C. Colombo, John Morrow, R. Te-Frey, Drew Dano, Hiroo Takayama, Yoshifumi Naka, Hasan Garan, Ulrich P. Jorde et al. · 2013 · Journal of the American College of Cardiology
29. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients
    Simonetta Genovesi, Maria Grazia Valsecchi, Emanuela Rossi, Daniela Pogliani, Irene Acquistapace, V. De Cristofaro, A Stella, A. Vincenti · 2009 · Nephrology Dialysis Transplantation
30. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy
    Barry J. Maron, Susan A. Casey, Raymond Ho Ming Chan, Ross Garberich, Ethan J. Rowin, Martin S. Maron · 2015 · The American Journal of Cardiology
31. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary
    Douglas Peter Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, BERNARD R. CHAITMAN, MARTIN A. FROMER, Gabriel Gregoratos, George Joseph Klein, Robert J. Myerburg, Miguel Angel Quiñones et al. · 2006 · Journal of the American College of Cardiology
32. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study)
    Rhidian J. Shelton, Andrew L. Clark, Kevin M Goode, Alan S. Rigby, Timothy Houghton, Gerry Kaye, John G.F. Cleland · 2009 · Heart
33. Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial
    Hohnloser, Stefan H., Dorian, Paul, Roberts, Robin, Gent, Michael, Israel, Carsten W., Fain, Eric, Champagne, Jean, Connolly, Stuart J. · 2006 · Circulation
34. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators
    Brian P. Betensky, Cory M. Tschabrunn, Erica S. Zado, Lee R. Goldberg, Francis E. Marchlinski, Fermin Carlos Garcia, Joshua M. Cooper · 2012 · Heart Rhythm
35. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy
    Tom F. Brouwer, Dilek Yilmaz, Robert Lindeboom, Maurits S. Buiten, Louise R.A. Olde Nordkamp, Martin Jan Schalij, Arthur A.M. Wilde, Lieselot van Erven, Reinoud E. Knops · 2016 · Journal of the American College of Cardiology
36. Sex Differences in Heart Failure
    Anuradha Lala, Upasana Tayal, CARINE E. HAMO, Quentin R. Youmans, Sana M. Al‐Khatib, Biykem Bozkurt, Melinda Baughman Davis, James L. Januzzi, Robert John Mentz, Andrew J. Sauer et al. · 2021 · Journal of Cardiac Failure
37. Depression and Anxiety Status of Patients with Implantable Cardioverter Defibrillator and Precipitating Factors
    Ahmet Kaya Bilge, Beste Özben, Sabri Demircan, MUTLU CINAR, Ercüment Yılmaz, Kâmil Adalet · 2006 · Pacing and Clinical Electrophysiology
38. Long‐term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction
    E. Agricola, A. Ielasi, M. Oppizzi, P. Faggiano, L. Ferri, A. Calabrese, E. Vizzardi, O. Alfieri, A. Margonato · 2009 · European Journal of Heart Failure
39. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
    Carlson, Mark D., Wilkoff, Bruce L., Maisel, William H., Carlson, Mark D., Ellenbogen, Kenneth A., Saxon, Leslie A., Prystowsky, Eric N., Alpert, Joseph S., Cain, Michael E., Ching, Elizabeth A. et al. · 2006 · Heart Rhythm
40. Wnt signaling: multiple functions in neural development
    Fabian Ille, Lukas Sommer · 2005 · Cellular and Molecular Life Sciences
41. Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association
    Rakesh Gopinathannair, Lin Y. Chen, Mina K. Chung, William K. Cornwell, Karen L. Furie, Dhanunjaya R. Lakkireddy, Nassir F. Marrouche, Andrea Natale, Brian Olshansky, José A. Joglar · 2021 · Circulation Arrhythmia and Electrophysiology
42. Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry
    Thomas A. Dewland, Cara N. Pellegrini, Yongfei Wang, Gregory M. Marcus, Edmund C. Keung, Paul D. Varosy · 2011 · Journal of the American College of Cardiology
43. Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure
    Nathan C. Denham, Charles Michael Pearman, Jessica L. Caldwell, George W. P. Madders, David A. Eisner, Andrew W. Trafford, Katharine M. Dibb · 2018 · Frontiers in Physiology
44. Medical Therapy for Heart Failure Caused by Ischemic Heart Disease
    Islam Y. Elgendy, Dhruv Mahtta, Carl J. Pepine · 2019 · Circulation Research
45. Stem Cell Therapy for Cardiac Repair
    Andrew Boyle, Steven P. Schulman, Joshua M. Hare · 2006 · Circulation
46. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association
    Rakesh Gopinathannair, William K. Cornwell, Jonathan Walter Dukes, Christopher Randall Ellis, Kathleen T. Hickey, José A. Joglar, Francis D. Pagani, Henri Roukoz, Mark S. Slaughter, Kristen K. Patton · 2019 · Circulation
47. Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
    Elfriede Pahl, Lynn A. Sleeper, Charles E. Canter, Daphne T. Hsu, Minmin Lü, Steven A. Webber, Steven D. Colan, Paul Fraser Kantor, Melanie D. Everitt, Jeffrey Allen Towbin et al. · 2012 · Journal of the American College of Cardiology
48. “That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators
    Nathan E. Goldstein, Davendra Mehta, Saima Aziz Siddiqui, Ezra N. Teitelbaum, Jessica A. Zeidman, Magdelena Singson, Elena Pe, Elizabeth H. Bradley, R. Sean Morrison · 2007 · Journal of General Internal Medicine
49. Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
    Justin Adrian Ezekowitz, Brian Hunter Rowe, Donna M Dryden, Nicola Hooton, Ben Vandermeer, Carol Spooner, Finlay Aleck McAlister · 2007 · Annals of Internal Medicine
50. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
    Barry J. Maron, Ethan J. Rowin, Susan A. Casey, John R. Lesser, Ross Garberich, Deepa M. McGriff, Martin S. Maron · 2015 · Circulation
51. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial
    Roderick H. Tung, Yumei Xue, Minglong Chen, Chenyang Jiang, Dalise Y. Shatz, Stephanie A. Besser, Hongde Hu, Fa-Po Chung, Shiro Nakahara, Young-Hoon Kim et al. · 2022 · Circulation
52. Clinical Cardiac Electrophysiology
    ANDREW C. RANKIN, F. Russell Quinn, Alan P. Rae · 2010 · Springer eBooks
53. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study
    Gianfranco Piccirillo, Damiano Magrì, Sabrina Matera, Marzia Magnanti, Alessia Torrini, Eleonora Pasquazzi, Erika Schifano, Stefania Velitti, Vincenzo Marigliano, Raffaele Quaglione et al. · 2006 · European Heart Journal
54. Status of Women in Cardiovascular Clinical Trials
    Esther S.H. Kim, Venu Menon · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
55. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias
    Jeff S. Healey, Al P. Hallstrom, Karl‐Heinz Kück, Girish M. Nair, Eleanor P. Schron, Robin S. Roberts, Carlos Arturo Morillo, Stuart J. Connolly · 2007 · European Heart Journal
56. Long-Term Outcomes of Dilated Cardiomyopathy Diagnosed During Childhood
    Peta M. A. Alexander, Piers E.F. Daubeney, Alan William Nugent, Katherine J. Lee, Christian Turner, Steven D. Colan, Terry Robertson, Andrew Mark Davis, James Ramsay, Robert N Justo et al. · 2013 · Circulation
57. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
    Henry Krum, Michael V Jelinek, Simon Stewart, Andrew Paul Sindone, John James Atherton, Anna L. Hawkes · 2006 · The Medical Journal of Australia
58. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Nikolaos Dagres, Gerhard Hindricks · 2013 · European Heart Journal
59. Leitlinien zur Therapie der chronischen Herzinsuffizienz
    Uta Charlotte Hoppe, Michael Böhm, Rainer Dietz, Peter Hanrath, Heyo K. Kroemer, Ady Osterspey, ACHIM A. SCHMALTZ, Erland Erdmann · 2005 · Zeitschrift für Kardiologie
60. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis
    Pasquale Santangeli, Gemma Pelargonio, Antonio Dello Russo, Michela Casella, Caterina Bisceglia, Stefano Bartoletti, Pietro Santarelli, Luigi Di Biase, Andrea Natale · 2010 · Heart Rhythm
61. Risk of Thromboembolism in Heart Failure
    Ronald S. Freudenberger, Anne S. Hellkamp, Jonathan L. Halperin, Jeanne E. Poole, Jill Anderson, George William Johnson, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy · 2007 · Circulation
62. The Many Faces of Heart Failure
    David Snipelisky, Sunit‐Preet Chaudhry, Garrick C. Stewart · 2018 · Cardiac Electrophysiology Clinics
63. Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation
    Jagmeet P. Singh, William Jackson Hall, Scott A McNitt, Hongyue Wang, James P. Daubert, Wojciech Zaręba, Jeremy Neil Ruskin, Arthur J. Moss · 2005 · Journal of the American College of Cardiology
64. Risk Stratification for Arrhythmic Sudden Cardiac Death
    Jeffrey J. Goldberger, Alfred E. Buxton, MICHAEL E. CAIN, Otto Costantini, Derek V. Exner, Bradley P. Knight, Donald M. Lloyd‐Jones, Alan Howard Kadish, Byron Kwock Lee, Arthur J. Moss et al. · 2011 · Circulation
65. HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
    Fred M Kusumoto, Hugh G Calkins, JOHN P. BOEHMER, Alfred E. Buxton, Mina K. Chung, Michael Robert Gold, Stefan Hans Hohnloser, Julia H. Indik, Richard Lee, Mandeep R. Mehra et al. · 2014 · Journal of the American College of Cardiology
66. Sudden Cardiac Death in the Young
    Michael John Ackerman, Dianne L. Atkins, John K. Triedman · 2016 · Circulation
67. Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement
    Andrew David Krahn, Douglas S. Lee, DAVID H. BIRNIE, Jeff S. Healey, Eugene Crystal, Paul Dorian, Christopher S. Simpson, Yaariv Khaykin, DOUGLAS A. CAMERON, Amir Janmohamed et al. · 2011 · Circulation Arrhythmia and Electrophysiology
68. Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
    Pasquale Santangeli, Luigi Di Biase, Antonio Dello Russo, Michela Casella, Stefano Bartoletti, Pietro Santarelli, Gemma Pelargonio, Andrea Natale · 2010 · Annals of Internal Medicine
69. Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy
    Louise R.A. Olde Nordkamp, Reinoud E. Knops, Gust H. Bardy, Yuri Blaauw, Lucas V.A. Boersma, Johannes S. Bos, Peter Paul H.M. Delnoy, Pascal F.H.M. van Dessel, Antoine H.G. Driessen, Joris R. de Groot et al. · 2012 · American Heart Journal
70. Ventricular Tachycardia Ablation
    Frédéric Sacher, Usha B. Tedrow, Michael E. Field, Jean‐Marc Raymond, Bruce A. Koplan, Laurence Mark Epstein, William G. Stevenson · 2008 · Circulation Arrhythmia and Electrophysiology
71. Myocardial Fibrosis as a Key Determinant of Left Ventricular Remodeling in Idiopathic Dilated Cardiomyopathy
    Pier Giorgio Masci, Robert J Schuurman, Andrea Barison, Andrea Ripoli, Michele Alessandro Coceani, Sara Chiappino, Giancarlo Todiere, Vera Srebot, Claudio Passino, Giovanni Donato Aquaro et al. · 2013 · Circulation Cardiovascular Imaging
72. JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
    Akihiko Nogami, Takashi Kurita, Haruhiko Abe, Kenji Andò, Toshiyuki Ishikawa, Katsuhiko Imai, Akihiko Usui, Kaoru Okishige, Kengo Kusano, Koichiro Kumagai et al. · 2021 · Journal of Arrhythmia
73. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis
    D. A. M. J. Theuns, Timothy W. Smith, M. G. Myriam Hunink, Gust H. Bardy, Luc J.L.M. Jordaens · 2010 · EP Europace
74. Cardiac Arrest and Sudden Cardiac Death
    Robert J. Myerburg, Agustín Castellanos · 2012 · Elsevier eBooks
75. Stage B Heart Failure
    Lee R. Goldberg, Mariell L Jessup · 2006 · Circulation
76. Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments
    Du-Guan Fu · 2015 · Cell Biochemistry and Biophysics
77. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study
    Markus Zabel, Rik Willems, Andrzej Lubiński, Axel Bauer, Josép Brugada, David Conen, Panagiota Flevari, Gerd P Hasenfuss, Martin Svetlošák, Heikki V. Huikuri et al. · 2020 · European Heart Journal
78. Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy-Defibrillator Recipients According to Rhythm Shocked
    Brian D. Powell, Leslie A. Saxon, JOHN P. BOEHMER, John D. Day, Francis Roosevelt Gilliam, Paul A. Heidenreich, Paul W. Jones, Matthew Rousseau, David L. Hayes · 2013 · Journal of the American College of Cardiology
79. Cardiomyopathy, familial dilated
    Matthew R.G. Taylor, Elisa Carniel, Luisa Mestroni · 2006 · Orphanet Journal of Rare Diseases
80. Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction
    Milton Packer, John J.V. McMurray · 2021 · European Journal of Heart Failure
81. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results
    Angelo Auricchio, Edward J. Schloss, Takashi Kurita, Albert Meijer, Bart Gerritse, STEVEN L. ZWEIBEL, Faisal Alsmadi, Charles T. Leng, Laurence D. Sterns · 2015 · Heart Rhythm
82. Sudden Cardiac Death
    Vikas P. Kuriachan, Glen Sumner, L. Brent Mitchell · 2015 · Current Problems in Cardiology
83. Clinical risk prediction with random forests for survival, longitudinal, and multivariate (RF-SLAM) data analysis
    Shannon Wongvibulsin, Kathérine C. Wu, Scott L. Zeger · 2019 · BMC Medical Research Methodology
84. Heart failure
    Henry Krum, William T. Abraham · 2009 · The Lancet
85. Ventricular Tachycardia Ablation
    Gustavo Soares Guandalini, Jackson Jeikai Liang, Francis E. Marchlinski · 2019 · JACC. Clinical electrophysiology
86. Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction
    Yogesh N.V. Reddy, Barry A. Borlaug, Bernard John Gersh · 2022 · Circulation
87. Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis
    Brandon C. Varr, Shirin Zarafshar, Terra R. Coakley, Michaela Liedtke, Richard A. Lafayette, Sally Arai, Stanley L. Schrier, Ronald M. Witteles · 2013 · Heart Rhythm
88. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators
    Rachel J. Lampert, Brian Olshansky, Hein Heidbüchel, Christine E. Lawless, Elizabeth Vickers Saarel, Michael John Ackerman, Hugh G Calkins, N.A. Mark Estes, Mark S. Link, Barry J. Maron et al. · 2017 · Circulation
89. Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
    Douglas S. Lee, Jack V. Tu, Peter C. Austin, Paul Dorian, Raymond K. Yee, Alice S. Chong, David Andrew Alter, Andreas Laupacis · 2007 · Journal of the American College of Cardiology
90. Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States
    Daniel J. Friedman, Craig S. Parzynski, Paul D. Varosy, Jordan M. Prutkin, Kristen K. Patton, Ali A. Mithani, Andrea M. Russo, Jeptha P. Curtis, Sana M. Al‐Khatib · 2016 · JAMA Cardiology
91. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients
    Maully J. Shah, Michael J. Silka, Jennifer N. Avari Silva, Seshadri Balaji, Cheyenne M. Beach, Monica N. Benjamin, Charles I. Berul, Bryan C. Cannon, Frank Cecchin, Mitchell I. Cohen et al. · 2021 · Heart Rhythm
92. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome
    Loes P. C. Hoebers, Bimmer E.P.M. Claessen, Joëlle Elias, George Dangas, Roxana Mehran, Josè P.S. Henriques · 2015 · International Journal of Cardiology
93. The Dilemma of ICD Implant Testing
    Charles D. Swerdlow, Andrea M. Russo, Paul DeGroot · 2007 · Pacing and Clinical Electrophysiology
94. Review of the Registry's Fourth Year, Incorporating Lead Data and Pediatric ICD Procedures, and Use as a National Performance Measure
    Stephen C. Hammill, Mark S. Kremers, Lynne Warner Stevenson, Paul A. Heidenreich, Christine M. Lang, Jeptha P. Curtis, Yongfei Wang, Charles I. Berul, Alan Howard Kadish, Sana M. Al‐Khatib et al. · 2010 · Heart Rhythm
95. Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-Defibrillator
    Alon Barsheshet, Arthur J. Moss, David Tsu-Chau Huang, Scott A McNitt, Wojciech Zaręba, Ilan Goldenberg · 2012 · Journal of the American College of Cardiology
96. Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy
    Benjamin F. Remo, Mark W. Preminger, Jason S. Bradfield, Suneet Mittal, Noel Boyle, Anuj Kumar Gupta, Kalyanam Shivkumar, Jonathan S. Steinberg, Timm Michael Dickfeld · 2014 · Heart Rhythm
97. Medicare Coverage of ICDs
    Mark McClellan, Sean Tunis · 2005 · New England Journal of Medicine
98. Seizure versus syncope
    Andrew B. McKeon, Carl J. Vaughan, Norman Delanty · 2006 · The Lancet Neurology
99. End-of-Life Care in Patients With Heart Failure
    David J. Whellan, Sarah J. Goodlin, Michael G. Dickinson, Paul A. Heidenreich, Connie Jaenicke, Wendy Gattis Stough, Michael W. Rich · 2014 · Journal of Cardiac Failure
100. Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
     Joseph L. Schuller, Matthew Michael Zipse, Thomas Christopher Crawford, Frank Matthias Bogun, John F. Beshai, Amit R. Patel, Nadera Sweiss, Duy T. Nguyen, Ryan G. Aleong, Paul D. Varosy et al. · 2012 · Journal of Cardiovascular Electrophysiology